Evaluation of chronic pancreatitis for epidemiologic and translational studies

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to prospectively evaluate chronic pancreatitis to understand the factors contributing to its onset and progression. The Coordinating and Data Management Center at MD Anderson Cancer Center will oversee data management and coordination, while patient recruitment will occur at various external clinical centers across the U.S. The study is part of a larger NIH-funded consortium focused on chronic pancreatitis, diabetes, and pancreatic cancer. It will utilize comprehensive data management systems to ensure regulatory compliance and protocol monitoring.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1\. Participants with chronic pancreatitis.

Exclusion Criteria:

ALL GROUPS EXCEPT GREEN GROUP I:

1. History of autoimmune or traumatic pancreatitis, or sentinel attack of acute necrotizing pancreatitis which results in suspected
2. Primary pancreatic tumors - pancreatic ductal adenocarcinoma, suspected cystic neoplasm (\>1 cms in size or main duct involvement), neuroendocrine tumors, and other uncommon tumors.
3. Pancreatic metastasis from other malignancies.
4. History of solid organ transplant, HIV/AIDS.
5. Known isolated pancreatic exocrine insufficiency (e.g. in the absence of any eligible inclusion criteria).
6. Participants must not have medical or psychiatric illnesses or ongoing substance abuse that in the investigator's opinion would compromise their ability to tolerate study interventions or participate in longitudinal follow up.
7. Patients with known abnormal creatinine (GFR \< 30) or renal failure (applies to patients with chronic upper abdominal pain of suspected pancreatic origin and suspected CP (Yellow) subgroups).
8. Failure to agree for longitudinal follow-up.
9. Known Pregnancy. All participants of childbearing potential, except if post-menopausal \[i.e. no menses for ≥2 years\] or had a hysterectomy, bilateral tubal ligation/clip (surgical sterilization) or surgical removal of both the ovaries), must have a negative urine or serum B-HCG pregnancy test documented within 2 days prior to any endoscopic or radiologic procedures done for research purposes. Any standard of care tests will follow institutional policies regarding pregnancy test.
10. Currently incarcerated.
11. Inability to get MRI/MRCP in patients with chronic abdominal pain of suspected pancreatic origin (Green II) or Suspected CP (Yellow groups) at baseline (e.g. metal object in the body which precludes performance of MRI).

Where it's running

• University of Texas MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Li Liang, PHD — M.D. Anderson Cancer Center
• Study coordinator: Li Liang, PHD
• Email: lli15@mdanderson.org
• Phone: 713-563-4276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Short-stay aggressive hydration to prevent post-ERCP pancreatitis

  This trial tests whether a short, high-volume IV hydration with Lactated Ringer's plus a rectal indomethacin can prevent post-ERCP pancreatitis in adults undergoing ERCP.

  Recruiting Westmead Hospital · Westmead, New South Wales · NCT07776561

• Phosphate therapy for adults with acute pancreatitis

  This study tests whether giving phosphate through an IV can help adults with acute pancreatitis treated in the emergency department.

  Recruiting Phase 2 Duke University · Durham, North Carolina · NCT07681050

• Cold water rinse plus rectal indomethacin to prevent pancreatitis after ERCP

  This will test whether rinsing the papilla with cold water plus a rectal indomethacin dose lowers the chance of pancreatitis for adults undergoing ERCP.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas · NCT07330284

• Preventing complications after high-risk Whipple (pancreatoduodenectomy) with hydrocortisone, octreotide, and a teres ligament patch

  This tests whether giving hydrocortisone and octreotide around surgery plus placing a teres ligament patch can lower major complications after Whipple surgery in patients with a small pancreatic duct.

  Recruiting Phase 4 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07262957

• Scrambler therapy for chronic pancreatitis pain

  We will test whether Scrambler Therapy can reduce persistent abdominal pain in adults with chronic pancreatitis who haven't found relief from standard treatments.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07174609

• Patient-reported outcomes after pancreatic surgery

  This project will see how pancreatic surgery affects quality of life and whether adults who have pancreatic resection feel satisfied with their decision over time.

  Recruiting at 2 sites University of Arizona · Phoenix, Arizona and 1 other locations · NCT07173257

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.